Objective Scratch Assessments Using Digital Health Technologies (DHTs) 

Overview

The compulsion to scratch negatively affects the quality of life of millions of people with a wide range of conditions, ranging from psoriasis and atopic dermatitis to chronic venous disease and some cancers.

Drug developers are left with the challenge of showing how their treatments reduce scratch. Traditional subjective physician assessments and patient reports used in clinical trials provide an incomplete picture of the effects of their medicines.

However, an objective scratch measure is now achievable through the use of wrist-worn wearable technology that is both non-invasive and easy to implement. Learn how in this ActiGraph white paper.